Gunsynd
A provider of skin microbiology and clinical dermatology services to the pharmaceutical and consumer healthcare markets in the United Kingdom.
Launch date
Employees
Market cap
AUD2.3m
Enterprise valuation
AUD2m (Public information from Sep 2024)
Share price
£0.00123 GUN.L
Company register number 05656604
London England (HQ)
Financials
Estimates*
| GBP | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| EBITDA | - | - | - | <1m | (3.0m) | 1.4m | <1m |
| Profit | - | - | - | (<1m) | 2.0m | (2.4m) | (1.7m) |
| EV / EBITDA | - | - | - | 14.0x | -1.4x | 1.0x | 1.9x |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
* | N/A | £250k | Post IPO Equity |
| Total Funding | - | ||
Related Content
Recent News about Gunsynd
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
